Predictors of skin and soft tissue infections in HIV-infected outpatients in the community-associated methicillin-resistant Staphylococcus aureus era

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 2, 2015, Pages 339-347

  Hemmige, V ^a   McNulty, M ^b   Silverman, E ^c   David, M Z ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ANTIINFECTIVE AGENT; METICILLIN;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CAUCASIAN; DIABETES MELLITUS; FEMALE; FOLLOW UP; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INTRAVENOUS CATHETER; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MEDICAID; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PSORIASIS; RETROSPECTIVE STUDY; RISK FACTOR; SKIN AND SOFT TISSUE INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; URBAN AREA; VIRUS LOAD; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; COMPLICATION; DRUG EFFECTS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MICROBIOLOGY; MIDDLE AGED; OUTPATIENT; SKIN; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

ADULT; ANTI-INFECTIVE AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; OUTPATIENTS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION;

EID: 84921735275     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2237-1     Document Type: Article

References (42)

1. Jevons MP (1961) “Celbenin” - resistant Staphylococci. BMJ 1(5219):124–125. doi:10.1136/bmj.1.5219.124-a
2. David MZ, Daum RS (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23(3):616–687. doi:10.1128/cmr.00081-09
3. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279(8):593–598
4. Hersh AL, Chambers HF, Maselli JH, Gonzales R (2008) National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 168(14):1585–1591. doi:10.1001/archinte.168.14.1585
5. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM (2006) Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 144(5):309–317
6. Manfredi R, Calza L, Chiodo F (2002) Epidemiology and microbiology of cellulitis and bacterial soft tissue infection during HIV disease: a 10-year survey. J Cutan Pathol 29(3):168–172. doi:10.1034/j.1600-0560.2002.290307.x
7. Imaz A, Pujol M, Barragán P, Domínguez MA, Tiraboschi JM, Podzamczer D (2010) Community associated methicillin-resistant Staphylococcus aureus in HIV-infected patients. AIDS Rev 12(3):153–163
8. Graber CJ, Jacobson MA, Perdreau-Remington F, Chambers HF, Diep BA (2008) Recurrence of skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a HIV primary care clinic. J Acquir Immune Defic Syndr 49(2):231–233. doi:10.1097/QAI.0b013e318183a947, 1999
9. Crum-Cianflone N, Weekes J, Bavaro M (2009) Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors. AIDS Patient Care STDs 23(7):499–502. doi:10.1089/apc.2008.0240
10. Diep BA, Chambers HF, Graber CJ, Szumowski JD, Miller LG, Han LL, Chen JH, Lin F, Lin J, Phan TH, Carleton HA, McDougal LK, Tenover FC, Cohen DE, Mayer KH, Sensabaugh GF, Perdreau-Remington F (2008) Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 148(4):249–257
11. Crum-Cianflone NF, Burgi AA, Hale BR (2007) Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. Int J STD AIDS 18(8):521–526. doi:10.1258/095646207781439702
12. Mathews WC, Caperna JC, Barber RE, Torriani FJ, Miller LG, May S, McCutchan JA (2005) Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 40(2):155–160
13. Lee NE, Taylor MM, Bancroft E, Ruane PJ, Morgan M, McCoy L, Simon PA (2005) Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 40(10):1529–1534. doi:10.1086/429827
14. Trinh TT, Short WR, Mermel LA (2009) Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in HIV-infected patients. J Int Assoc Physicians AIDS Care (Chic) 8(3):176–180. doi:10.1177/1545109709335750
15. Srinivasan A, Seifried S, Zhu L, Bitar W, Srivastava DK, Shenep JL, Bankowski MJ, Flynn PM, Hayden RT (2009) Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIV. AIDS Res Hum Retroviruses 25(12):1219–1224. doi:10.1089/aid.2009.0040
16. Popovich KJ, Weinstein RA, Aroutcheva A, Rice T, Hota B (2010) Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis 50(7):979–987. doi:10.1086/651076
17. Krucke GW, Grimes DE, Grimes RM, Dang TD (2009) Antibiotic resistance in Staphylococcus aureus-containing cutaneous abscesses of patients with HIV. Am J Emerg Med 27(3):344–347
18. Ramsetty SK, Stuart LL, Blake RT, Parsons CH, Salgado CD (2010) Risks for methicillin-resistant Staphylococcus aureus colonization or infection among patients with HIV infection. HIV Med 11(6):389–394. doi:10.1111/j.1468-1293.2009.00802.x
19. Skiest D, Brown K, Hester J, Moore T, Crosby C, Mussa HR, Hoffman-Roberts H, Cooper T (2006) Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med 7(6):361–368. doi:10.1111/j.1468-1293.2006.00394.x
20. Szumowski JD, Wener KM, Gold HS, Wong M, Venkataraman L, Runde CA, Cohen DE, Mayer KH, Wright SB (2009) Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men. Clin Infect Dis 49(1):118–121. doi:10.1086/599608
21. Crum-Cianflone NF, Grandits G, Weintrob A, Ganesan A, Agan B, Landrum M (2012) Skin and soft tissue infections among HIV-infected persons in the late combination antiretroviral therapy era. Int J STD AIDS 23(7):507–511. doi:10.1258/ijsa.2011.011360
22. Vyas KJ, Shadyab AH, Lin CD, Crum-Cianflone NF (2014) Trends and factors associated with initial and recurrent methicillin-resistant Staphylococcus aureus (MRSA) skin and soft-tissue infections among HIV-infected persons: an 18-year study. J Int Assoc Provid AIDS Care 13(3):206–213. doi:10.1177/2325957412473780
23. Shadyab AH, Crum-Cianflone NF (2012) Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature. HIV Med 13(6):319–332. doi:10.1111/j.1468-1293.2011.00978.x
24. Cole J, Popovich K (2013) Impact of community-associated methicillin resistant Staphylococcus aureus on HIV-infected patients. Curr HIV/AIDS Rep 10(3):244–253. doi:10.1007/s11904-013-0161-0
25. Centers for Disease Control and Prevention CDC (2005) Community associated MRSA information for clinicians. Infection control topics (3 February 2005). CDC, Atlanta, GA.
26. Yelland LN, Salter AB, Ryan P (2011) Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol 174(8):984–992. doi:10.1093/aje/kwr183
27. Cox DR (1972) Regression models and life-tables. J R Stat Soc B 34(2):187–220
28. Giordano TP, Gifford AL, White AC Jr, Suarez-Almazor ME, Rabeneck L, Hartman C, Backus LI, Mole LA, Morgan RO (2007) Retention in care: a challenge to survival with HIV infection. Clin Infect Dis 44(11):1493–1499. doi:10.1086/516778
29. Anderson JP, Tchetgen Tchetgen EJ, Lo Re V 3rd, Tate JP, Williams PL, Seage GR 3rd, Horsburgh CR, Lim JK, Goetz MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Klein MB, Justice AC (2014) Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans. Clin Infect Dis 58(5):719–727. doi:10.1093/cid/cit779
30. Hosmer DW, Lemeshow S (2011) Applied survival analysis: regression modeling of time to event data. Wiley, Hoboken
31. Popovich K, Hota B, Rice T, Aroutcheva A, Weinstein RA (2007) Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus. J Clin Microbiol 45(7):2293–2295. doi:10.1128/jcm.00044-07
32. Hidron AI, Moanna A, Rimland D (2011) The rise and fall of methicillin-resistant Staphylococcus aureus infections in HIV patients. AIDS 25(7):1001–1003
33. Delorenze GN, Horberg MA, Silverberg MJ, Tsai A, Quesenberry CP, Baxter R (2013) Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients. Epidemiol Infect 141(11):2392–2402. doi:10.1017/s0950268813000228
34. Landrum ML, Neumann C, Cook C, Chukwuma U, Ellis MW, Hospenthal DR, Murray CK (2012) Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005–2010. JAMA 308(1):50–59. doi:10.1001/jama.2012.7139
35. Popovich KJ, Hota B, Aroutcheva A, Kurien L, Patel J, Lyles-Banks R, Grasso AE, Spec A, Beavis KG, Hayden MK, Weinstein RA (2013) Community-associated methicillin-resistant Staphylococcus aureus colonization burden in HIV-infected patients. Clin Infect Dis 56(8):1067–1074. doi:10.1093/cid/cit010
36. Peters PJ, Brooks JT, McAllister SK, Limbago B, Lowery HK, Fosheim G, Guest JL, Gorwitz RJ, Bethea M, Hageman J, Mindley R, McDougal LK, Rimland D (2013) Methicillin-resistant Staphylococcus aureus colonization of the groin and risk for clinical infection among HIV-infected adults. Emerg Infect Dis 19(4):623–629. doi:10.3201/eid1904.121353
37. Cook HA, Furuya EY, Larson E, Vasquez G, Lowy FD (2007) Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 44(3):410–413. doi:10.1086/510681
38. Roberts JR (2007) Lap dancer’s lament: an occupational hazard related to community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 49(1):116–117. doi:10.1016/j.annemergmed.2006.08.034
39. Centers for Disease Control and Prevention (CDC) (2009) Methicillin-resistant Staphylococcus aureus among players on a high school football team—New York City, 2007. MMWR Morb Mortal Wkly Rep 58(3):52–55
40. Siberry GK, Frederick T, Emmanuel P, Paul ME, Bohannon B, Wheeling T, Barton T, Rathore MH, Dominguez KL (2012) Methicillin-resistant Staphylococcus aureus infections in human immunodeficiency virus-infected children and adolescents. AIDS Res Treat 2012:627974. doi:10.1155/2012/627974
41. Gonzalez BE, Rueda AM, Shelburne SA 3rd, Musher DM, Hamill RJ, Hulten KG (2006) Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 27(10):1051–1056. doi:10.1086/507923
42. Pasquale TR, Jabrocki B, Salstrom SJ, Wiemken TL, Peyrani P, Haque NZ, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, File TM Jr (2013) Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA. Int J Infect Dis 17(6):e398–e403. doi:10.1016/j.ijid.2012.12.013